Last10K.com

Applied Biosciences Corp. (APPB) SEC Filing 10-K Annual report for the fiscal year ending Sunday, March 31, 2019

Applied Biosciences Corp.

CIK: 1607549 Ticker: APPB
Document and Entity Information - USD ($)
12 Months Ended
Mar. 31, 2019
Jun. 26, 2019
Sep. 30, 2018
Document And Entity Information   
Entity Registrant NameAPPLIED BIOSCIENCES CORP.  
Entity Central Index Key0001607549  
Document Type10-K  
Document Period End DateMar. 31, 2019  
Amendment Flagfalse  
Current Fiscal Year End Date--03-31  
Is Entity a Well-known Seasoned Issuer?No  
Is Entity a Voluntary Filer?No  
Is Entity's Reporting Status Current?Yes  
Entity Filer CategoryNon-accelerated Filer  
Entity Public Float  $ 10,259,104
Entity Common Stock, Shares Outstanding 13,447,113 
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2019  
Entity Emerging Growth Companytrue  
Entity Small Businesstrue  
Entity Ex Transition Periodfalse  
Entity Shell Companyfalse  

View differences made from one year to another to evaluate Applied Biosciences Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Applied Biosciences Corp..

Continue

Assess how Applied Biosciences Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Applied Biosciences Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statement Of Stockholders Equity
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Acquisition Of Trace Analytics, Inc.
Acquisition Of Trace Analytics, Inc. (Details 1)
Acquisition Of Trace Analytics, Inc. (Details Narrative)
Acquisition Of Trace Analytics, Inc. (Details)
Acquisition Of Trace Analytics, Inc. (Tables)
Business Segment And Geographic Reporting
Business Segment And Geographic Reporting (Details Narrative)
Commitment And Contingencies
Commitment And Contingencies (Details Narrative)
Convertible Notes
Convertible Notes (Details Narrative)
Equity
Equity (Details Narrative)
Equity Investments
Equity Investments (Details Narrative)
Equity Investments (Details)
Equity Investments (Tables)
Income Taxes
Income Taxes (Details 1)
Income Taxes (Details Narrative)
Income Taxes (Details)
Income Taxes (Tables)
Notes Payable
Notes Payable (Details Narrative)
Organization And Basis Of Presentation
Organization And Basis Of Presentation (Details Narrative)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Tables)
Related Party Transactions
Related Party Transactions (Details Narrative)
Subsequent Events
Subsequent Events (Details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)

Material Contracts, Statements, Certifications & more

Applied Biosciences Corp. provided additional information to their SEC Filing as exhibits

Ticker: APPB
CIK: 1607549
Form Type: 10-K Annual Report
Accession Number: 0001477932-19-003830
Submitted to the SEC: Mon Jul 01 2019 5:25:11 PM EST
Accepted by the SEC: Mon Jul 01 2019
Period: Sunday, March 31, 2019
Industry: Heating Equip Except Elec And Warm Air And Plumbing Fixtures

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/appb/0001477932-19-003830.htm